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Abstract 
Shape memory polymer (SMP) foams provide a promising new option for 
hemorrhage control on the battlefield; however, they lack a mechanism to control wound 
infections that can delay healing processes. Adding phenolic acids (PAs) into SMP foams 
provides a natural, non-drug option for incorporations of antioxidant and antimicrobial 
functionalities that may promote healing. However, PAs lack a systemic characterization 
of their structure/property relationships, and their chemical incorporation into SMP foams 
may alter their efficacy. In this work, a library of PAs was screened in terms of antioxidant 
and antimicrobial properties to provide a full understanding of how their structure affects 
their function. Additionally, a subset of PAs was modified with SMP foam analog 
monomers (modified PAs, MPAs) and compared to their unmodified counterparts. PA and 
MPA antioxidant capabilities were tested in terms of hydrogen peroxide scavenging 
capacity, and their antimicrobial activities were evaluated against both gram-positive and 
gram-negative bacteria strains. After testing, the PA library was narrowed down from 10 
to 5 candidates with the best solubility, antioxidant properties, and antimicrobial properties. 
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1. Introduction  
1.1 Clinical Need: Uncontrolled Hemorrhage   
Among the potentially survivable battlefield injuries that resulted in death, 80% of them 
are due to uncontrolled hemorrhage from major trauma,[1] and up to 50% of deaths occur 
outside of hospital.[2] Uncontrolled hemorrhage will lead to great blood loss. Losing 50% 
of blood volume without resuscitation is usually fatal, while patients with reduced blood 
pressure (those who have lost 30% to 35% of blood volume) are close to death.[3] 
Therefore, it is important to quickly mitigate bleeding before one can receive hospital 
treatment. Additionally, almost half of traumatic wounds get polymicrobial infections on 
the battle field.[4] After infection, the skin-bacteria inflammatory response will release 
collagenases and contribute to the collagen degrading, which can delay healing.[5] The 
current standard of care is to deliver broad spectrum oral antibiotics after injury,[6] but 
this approach is ineffective at eliminating infections and is complicated by the emergence 
of drug-resistant bacteria strains.[7] As a result, first-aid treatments for uncontrolled 
hemorrhage could be improved if they could provide a localized antimicrobial effect in the 
wound. 
 
1.2 Current Solutions: Benefits and Limitations  
Currently, the most common medical treatment to control blood loss includes the use 
of gauze and tourniquets. Gauze comprises a traditional wound dressing product that 
simply covers wounds, and it is used for bleeding from small arteries, veins, and 
capillaries with applied pressure. For severe conditions like large arterial bleeding, 




treatments are insufficient for up to 80% of bleeds. Additionally, gauze dressings do not 
protect against infection and adhere to the wounds, which makes it difficult and painful to 
remove in the subsequent treatments. As for tourniquets, their use is limited to relative 
short time frames (<6 hours), as prolonged tourniquet use may lead to wound 
complications, including nerve damage and limb loss.[8] 
Due to the limitations of gauze and tourniquets, a large number of clinically-available 
first-aid treatments for gunshot wounds have been introduced. There are several kinds of 
topical hemostatic agents including gelatin foams, thrombin, chitin, chitosan, and oxidized 
cellulose. Gelatin foams like Gelfoam (Pfizer), provide a physical matrix for clotting. They 
function effectively for small vessel bleeding, and they are biological and absorbable. 
However, because of their swelling capability, gelatin foams could not be used in closed 
spaces as they can cause nerve compression around the wound; additionally, they do not 
protect against infection. Thrombin is able to convert fibrinogen to fibrin to help clots form. 
Thrombin dressings are easy to apply and fast acting, but bovine thrombin may cause an 
immunologic response. Chitin and chitosan are designed for emergency cases and they 
function as a mechanical seal. Chitin dressings are not reliable for severe wounds and 
chitosan dressings still have inconsistent results in the animal testing.[9] A promising new 
hemostat for gunshot wounds is XStat®, an oxidized cellulose material with ~96 small 
sponges that can be injected into a wound. After application, the cellulose micro-sponges 
expand quickly and apply pressure to wound walls to cut off blood flow. However, each 
sponge must be individually removed from the wound within four hours of application. The 




injury and increase infection susceptibility, and this option is limited in prolonged field care 
scenarios when frequent dressing changes are not feasible.[10] 
 
1.3 Shape Memory Polymer (SMP) Foams 
To address the limitations of current hemostats, we propose to develop a new, 
antimicrobial SMP foam. SMP foams are smart materials with multiple biomedical 
applications. They are fabricated as expanded, open-porous foams, and they can be 
heated, deformed into a secondary, compressed shape, cooled down, and stored for long 
time frames. When the environmental temperature is increased above their glass 
transition temperature (Tg), SMP foams expand rapidly from the compressed secondary 
shape to their original shape. By tuning monomers, chemical formulations, and foaming 
parameters, it is possible to customize the material’s thermal, mechanical, and shape 
memory properties.[11] 
SMP foams have excellent biocompatibility and demonstrate rapid clotting in 
aneurysms and peripheral vasculature.[12][13][14][15][16] Previous work has focused on 
incorporating new functionalities into SMP foams, including degradability and X-ray 
imaging capabilities.[17][18][19][12] Due to their excellent clotting capabilities, 
researchers have also previously explored the use of SMP foams for hemorrhage control. 
A device was developed that combines SMP foams and iodine-containing poly (ethylene 
glycol) (PEG) hydrogels with the capacity for rapid clotting and swelling.[18] The results 
showed that the PEG-based SMP foams with iodine maintain shape memory behavior, 
increase water absorption, and reduce bacteria viability. However, inclusion of the 




on the battlefield. Additionally, research suggests that iodine can be detrimental to wound 
healing,[20] which makes exploration of other antimicrobial options a necessity.  
 
1.4 Phenolic Acids 
Due to the limitations of traditional antibiotics, there is a growing interest in nondrug-
based techniques to fabricate antimicrobial medical devices. Honey has long been used 
to treat a variety of wounds, including burns and ulcers that are infected or chronic.[21] 
Honey dressings can speed up the healing of pressure wounds and they are also used 
to reduce wound stench.[22] These effects are due in part to two kinds of essential 
antimicrobial substances in honey, flavonoids and phenolic acids (PAs). It has been 
shown that high concentrations of flavonoids and PAs can improve honey’s antimicrobial 
capabilities.[22]  
PAs contains a carboxylic acid group on their non-active end that enables their 
incorporation into the polyurethane SMP foam system; thus, they were selected for further 
exploration in these studies. A number of studies have been performed on PA 
antimicrobial characterization; however, many studies focus on the use of PAs in relation 
to food-borne illnesses and plant pathogens rather than common wound bacteria, such 
as E. coli, Staph. epi., and Staph. aureus. No PAs have been characterized against all 
strains of interest, many are lacking data on drug-resistant strains, and some of the data 
is conflicting (e.g. ferulic and vanillic acids were determined to be effective against E. coli 
in studies performed by Merkl et al. but not in those performed by Chatterjee et al.).[23] 




Phenolic acids, as secondary metabolites of plants that could kill microorganisms or 
inhibit the growth of bacteria, have been involved in the plant’s antimicrobial mechanisms. 
Inhibitory mechanisms of phenolic acids on bacteria growth include, but are not limited to, 
destabilizing the bacteria cytoplasmic membrane, altering the permeability of the bacteria 
plasma membrane, inhibition of the extracellular microbial enzymes, direct effects on 
microbial metabolism, and the deprivation of the substrate required for microbial 
growth.[25] Firstly, phenolic acids could affect bacteria cells by changing their 
physicochemical surface properties. For example, ferulic acid could promote the 
decrease of hydrophobic character of P. aeruginosa.[26] Phenolic acid treatment could 
also make gram-positive bacteria strains acquire polar character by measuring the values 
of the bacteria’s surface tension components. Phenolic acids have effects on bacteria’s 
surface electron receptor of both gram-positive (increased receptor components) and 
gram-negative (decreased receptor components) bacteria strains. [26] Secondly, 
phenolic acids have effects on the integrity of bacterial cytoplasmic membrane. As the 
concentrations of phenolic acids increase, the percentage of cell membrane damage 
shows a significant increase. But different phenolic acids have various effects on gram-
positive and gram-negative bacteria strains. Last but not least, the promotion on the 
release of potassium in bacterial cells is also a part of phenolic acid’s antimicrobial 
mechanisms. The control groups show more intracellular K+ residual compared with 
groups after phenolic acid treatment. And the release of K+ by gram-negative bacteria 
strains is more than for the gram-positive bacteria strains.[26] 
Previously, cinnamic acid (CA) was incorporated into SMP foams, providing a material 




acids including CA don’t need to be released or solubilized from the SMP network to be 
functional. Because all PAs are composed of a carboxylic group (for incorporating PAs 
into the SMP network) and a benzene ring linked with hydrogen donating groups 
(functional group). Therefore, PAs are still effective after tethering to the SMP network, 
because only carboxylic group changes during the synthesis process, their functional 
group and our desired properties stay. CA-based foams retained high cytocompatibility 
and reduced E. coli and Staph. epi. growth, indicating the feasibility of use of PAs to 
provide antimicrobial SMPs. In addition to their antimicrobial properties, PAs contain 
hydrogen donating groups that can react with oxidants to form resonance-stabilized 
phenoxyl radicals and provide antioxidant properties that could further improve healing 
outcomes.[23][28][29][30] PAs, as antioxidants, play an essential role in traumatic wound 
healing. Because PAs could react with reactive oxygen species (ROS) released from 
neutrophils and macrophages.[31] The excessive amount of ROS is always present in 
chronic wounds, and a great method to interrupt chronic inflammatory cycle is removing 
ROS with antioxidants.[31] In addition to that, ROS are able to create highly oxidizing 
environments for traumatic wounds, and the drastically increase of the ROS production 
can cause human body’s oxidative stress response leading to critical illness (for example, 
organ dysfunction, disseminated intravascular coagulation, and the presence of an acute 
phase response).[30][32][33][34] Although ROS are considered to have certain beneficial 
antimicrobial properties, prolonged exposure of acute and chronic wounds to high levels 
of ROS causes cell damage and inhibits wound healing.[31] Using honey-based PAs, as 
free radical scavengers that could block the ROS-induced cytotoxicity, to lower the 




death.[31] The long-term goal of our research is to incorporate honey based phenolic 
acids into the SMP networks to provide antioxidant and antimicrobial scaffolds. PA-
containing SMPs are expected to promote traumatic healing and lower the risk of bacterial 
infection of gram-positive, gram-negative, and drug-resistant bacteria strains.  
To reach this goal, the focus of this thesis is to characterize a library of PAs and 
establish their structure/property relationships. This work will aid in rational design of PA-
containing biomaterials with desired functionality. Ten PAs were selected to characterize 
in terms of antimicrobial and antioxidant properties, Figure 1. The PAs without pendant 
hydroxyl (OH) groups on the ring structures (benzoic acid (BA) and CA) are not expected 
to demonstrate antioxidant properties. Additional BA- and CA-based PAs were chosen 
with varied pendant groups (1 OH group, 1 OH group with 1 or 2 methoxy groups, and 2 
OH groups). All selected PAs in this research are expected to have varying degrees of 
antimicrobial efficacy, and antioxidant properties are hypothesized to be tied to pendant 
group chemistry. 
This study fills in understanding the properties of the PAs with pendent group 
variations, providing relationships between structure and properties by screening the 10 
selected PAs in terms of antimicrobial properties against 5 common pathogenic wound 
bacteria and antioxidant properties. An additional consideration is reaction of the 
carboxylic acid group on PAs during SMP synthesis and its potential effects on PA 
functionality. To address this issue, PAs that were modified with foaming monomer 






Figure 1. Ten selected PAs and their chemical structures. Top row: CA-based PAs; 


















2. Methods and Materials 
2.1 Modified Phenolic Acid (MPA) Synthesis 
Approximately 3 g of each PA was dried overnight under vacuum and dissolved in 
anhydrous dimethyl sulfoxide (DMSO) in a reaction flask at ~0.1 g/ml. Hexyl isocyanate 
(HI) (1.1 molar equivalents) was added dropwise to the reaction under anhydrous 
conditions. The solution was reacted under nitrogen at 65°C for ~72 hours, or until the 
isocyanates were fully reacted, as indicated by a disappearance of the isocyanate peak 
at ~2250 cm-1 in the Fourier transform infrared spectroscopy (FTIR) spectra of the 
reaction contents. 
Complete reaction resulted in separation of the reaction contents into a ‘viscous’ and 
‘liquid’ portion. Gravity filtration was applied to the solution with a short stem funnel and 
filter paper to separate the viscous and liquid portions. The product was precipitated from 
the filtered liquid portion in cold water at a 1:5 volume ratio (liquid portion: cold water). 
Then, the solution was centrifuged in 4000 rpm for 15 minutes. The target MPA product 
was separated from the solvent and dried under vacuum overnight. The MPA structure 
was analyzed using FTIR and nuclear magnetic resonance (NMR) spectroscopy. 
 
2.2 PA and MPA Antioxidant Test  
The antioxidant capacity of the 10 PAs and corresponding MPAs was measured 
based on their H2O2 scavenging capabilities as previously described. All selected PAs 
and MPAs were dissolved in DMSO at 5 mg/ml. A 0.002% H2O2 solution was prepared in 
water, a 0.1M phosphate-buffered saline (PBS) solution was prepared in water, dying 




and 0.1 mg/ml, respectively, and a 1M sodium hydroxide solution was prepared in water. 
Each PA was serially diluted from 5 to 0.078 mg/ml in 10 μl DMSO in wells of a 96-well 
plate, as shown in Figure 2. Blank solutions (10 ul DMSO) were also included in each 
plate. Then, 10 μl of the prepared H2O2 solution and 80 μl of PBS were added to each 
sample well. After 10 minutes incubation at 37°C, 100 μl of the prepared dying agents 
was added. Subsequently, the plate was incubated for 15 minutes in at 37°C, and 5 μl of 
the prepared sodium hydroxide solution was added to each sample well. Hydrogen 
peroxide scavenging was analyzed immediately after addition of sodium hydroxide using 
a plate reader at an absorbance of 610 nm (O.D. 610). Each sample was tested in 
triplicate, and all selected PAs and MPAs were tested with this method. 
 
 
Figure 2. General test setup for antioxidant and antimicrobial analysis on 96 well plate. 
Each acid was tested in triplicate in columns 1-3, 4-6, 7-9, and 10-12 (4 acids per plate). 





 The antioxidant properties of PAs were quantified in terms of H2O2 scavenging 
activity (Hs) using Equation 1: 
𝐻" = 100%	 ×	[𝐶+ −	(𝐶+.+/ 	× 	𝐶+)]                                                                   Equation 1 
where C0 is the absorbance value of the control group with no PA and C0.05 is the 
absorbance value of the PA sample at the specific concentration. 
 
2.3 PA and MPA Antimicrobial Tests 
2.3.1 Preparation of Bacteria Strains 
In this study, we used Escherichia coli (E. coli), Staphylococcus epidermidis (Staph. 
epi., native and drug-resistant) and Staphylococcus aureus (Staph. aureus, native and 
drug-resistant) to test the efficacy of PA antimicrobial properties. Before incubating with 
PAs, bacteria strains were grown in 5 ml of fresh LB broth (prepared at 25 g/L of deionized 
water and autoclaved) at 37°C for ~16-17 hours. Subsequently, 1ml of the 5ml bacteria 
medium was taken and cultured in 9 ml of fresh LB broth until bacteria reached the 
logarithmic growth period when optical density at an absorbance of 600 nm (O.D. 600) 
value equals 0.6. The O.D. value was measured using a plate reader.  
 
2.3.2 Multi-Well Plate Assay 
2.3.2.1 DMSO Bacterial toxicity 
Before testing PAs antimicrobial performance, each bacteria strain was cultured 
with a range of concentrations of DMSO in multi-well plates. This testing was to ensure 
that DMSO does not affect the growth of bacteria strains and interfere with measurements 




bacteria. Different volumes (0, 1, 2, 4, 8, 16, 32, 64, and 128 μl) of DMSO were added to 
LB broth in a well; each well contained a total of 200 μl of DMSO/LB broth solution. Each 
concentration of DMSO was tested in triplicate. Then, 20 μl of the prepared log-phase 
growth bacteria medium was added into each well. The plate was placed in a 37°C shaker 
table for 24 hours. Bacteria growth was analyzed via plate reader absorbance readings 
at O.D. 600 at 0, 1, 2, 4, and 24 hours with a goal of finding the maximum volume of 
DMSO that could be used in PA testing without affecting the growth of bacteria 
(comparable O.D. 600 value to 0 μl samples). 
 
2.3.2.2 PA Characterization 
From the DMSO test, it was found that E. coli could be exposed to 5 μl DMSO, and 
Staph. epi. and Staph. aureus could be exposed to 10 μl DMSO without negatively 
affecting growth. Therefore, PAs were serially diluted from 5 to 0.078 mg/ml in 5 μl DMSO 
and 95 μl of fresh LB broth for E. coli tests and in 10 μl DMSO and 90 μl of fresh LB broth 
for Staph. epi. and Staph. aureus tests. Controls included wells with 5 or 10 μl DMSO in 
95 or 90 μl of fresh LB broth (DMSO control), 100 μl LB broth (LB control), and a 1% 
penicillin-streptomycin solution in 5 or 10 μl DMSO and LB broth (drug control). For the 
drug-resistant strains, 1% methicillin or oxacillin solution was prepared in DMSO and LB 
broth as additional drug controls. After that, 20 μl of prepared log-phase growth bacteria 
medium and 100 μl fresh LB broth was added to all wells in the plate. Bacterial growth 
was tested via absorbance readings at O.D. 600 at 0, 1, 2, 4, and 24 hours. Every sample 
was tested in triplicate, and all 10 selected PAs were tested using this method. Results 




IC50 is the measure of the concentration of antimicrobial agent required to kill 50% of 
bacteria. It illustrates potency of inhibiting bacteria growth and provides information on 
minimal concentrations required for future incorporation into antimicrobial SMP scaffolds. 
IC50 was calculated with Using Equations 2 and 3: 
𝐻𝑎𝑙𝑓	𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 = <=><?
@




                                                                                   Equation 
3 
where C0 is the O.D. value of DMSO group; C1 is the O.D. value of the drug control 
group; b is the y-intercept of the bacteria’s growth curve relative to PA concentration; and 
a is the slope of the bacteria’s growth curve relative to PA concentration. 
Log reduction is the measure of how a specified concentration of antimicrobial reduces 




)                                                                                 Equation 
4 
where C0 is the O.D. value of the DMSO control and C1 is the O.D. value of a PA or 
MPA. 
 
2.3.2.3 Petri Dish Assay 
Due to low solubility of PAs in aqueous solvents, sediment was observed in some 
wells with higher concentration of PA samples, which affected absorbance readings in 




acid, cinnamic acid, and p-coumaric acid) also had low solubility, which affected 
absorbance readings. To address this issue, a Petri dish assay was applied to quantify 
the antimicrobial properties of MPAs and PAs with low solubility. 
LB-agar (LB at 20 g/L, agar at 15 g/L) was prepared in deionized water, autoclaved, 
poured into Petri dishes, and allowed to gel overnight. Each PA for which sediment was 
observed in a study with a specific bacteria strain was selected. Every selected PA was 
dissolved at 5 mg/ml in 20 μl DMSO and mixed with 380 μl fresh LB broth in a 24 well 
plate. Fresh LB broth (400 μl) and 20 μl DMSO in 380 μl LB broth were used as controls. 
Subsequently, 40 μl of prepared log-phase growth bacteria medium was added to each 
well in the plate. Each sample was tested in triplicate. 
At 2, 4, and 24 hours, 10 μl of the bacteria medium was extracted from each sample 
well and diluted by 10,000 in fresh LB. Then, 100 μl of the diluted solution was applied to 
the surface of Petri dishes and cultured for 24 hours at 37°C. Photographs were obtained 
of each plate surface after culturing, and ImageJ software was used to quantify colony 














3. Results and Discussion 
3.1 PA and MPA Antioxidant Properties 
In general, reaction of hydroxyl groups with oxidizing agents (e.g. reactive oxygen 
species) forms resonance-stable phenoxy radicals, which enables phenols to have 
antioxidant properties.[29] Therefore, we hypothesized that PAs that do not contain 
pendant hydroxyl (OH) groups (cinnamic and benzoic acid controls) would not 
demonstrate antioxidant capability. In this experiment, hydrogen peroxide (H2O2) was 
utilized as an oxidizing agent to quantify the antioxidant properties of 10 selected PAs. 
Then, the antioxidant properties of PAs were quantified in terms of H2O2 scavenging 
activity. Successful H2O2 scavenging was taken to be greater than 50%.[28]  
Figure 3 shows the H2O2 scavenging capabilities of both benzoic acid (BA) and 
cinnamic acid (CA) groups. From these results, the relative antioxidant capacity of PAs 
can be seen in terms of H2O2 scavenging capabilities. For BA group, Figure 3A, BA does 
not demonstrate antioxidant capacity, and 4-hydroxy benzoic acid (4-HBA) with only one 
OH group has the second lowest antioxidant capacity. These results are in line with the 
hypothesis. With the addition of methoxy and additional hydroxyl groups in protocatechuic 
acid (PA), syringic acid (SYA) and vanillic acid (VA), their antioxidant efficacy is 
significantly increased. The addition of functional pendant groups on PA, SYA, and VA 
enables more effective formation of resonance-stabilized phenoxy radicals, which imparts 
stronger antioxidant capacity. As for CA group, Figure 3B, CA does not demonstrate 




other CA-based PAs resulted in significantly improved antioxidant capabilities compared 
with CA. 
 
Figure 3. Hydrogen peroxide scavenging capabilities of PAs from the (A) Benzoic acid 
group and (B) Cinnamic acid group. 
 
Upon characterization of unmodified PA antioxidant capabilities, the antioxidant 
properties of modified PAs (MPAs) were characterized to test whether PAs maintain their 
antioxidant capacity after the chemical modification required for incorporation into SMP 
foams. Figure 4 shows the H2O2 scavenging capabilities of currently synthesized MPAs, 
modified benzoic and syiringic acids from the BA group (Figure 4A) and modified 






seen that modified BA retains low antioxidant capacity at levels that are similar to those 
of BA. Similarly, syringic acid and modified syringic acid have comparable antioxidant 
efficacy. The CA group shows the same trend in that CA and modified CA both have low 
H2O2 scavenging capabilities, while p-coumaric acid (P-CA) and modified P-CA have 
similarly increased antioxidant properties. These results indicate that the chemical 
modification of PAs that is required for their incorporation into SMP foams will not alter 
their antioxidant capacity, enabling future synthesis of antioxidant SMP scaffolds. 
Antioxidant SMP scaffold, as polymeric medical devices with extended biostability, have 
various potential applications. Additives in SMPs that have oxygen radical scavenging 
capabilities could inhibit the oxidative mechanisms of degradation, which can cause 
scission and crosslinking of polyurethane chains.[35] With the presence of antioxidants 
in the network, it is possible to control the SMP’s degradation. Therefore, with controlled 
degrading rate, the SMPs could be made as microparticles in the drug delivery system. 
For example, the SMPs with antioxidants could deliver superoxide dismutase to a model 
of lung fibrosis without inflammatory response.[36] Except for the applications in the 
aspect of degradation, the antioxidant SMP scaffolds also have healing benefits. Studies 
have shown that the onset of varieties of diseases such as rheumatoid arthritis, 
atherosclerosis, and cancer is related to the presence of free radicals and excess reactive 
oxygen species. The development of SMP scaffolds with antioxidants could help lower 
the concentration of these compounds. Moreover, the excess amount of reactive oxygen 
species is able to prevent the process of wound healing, the antioxidants-present SMPs 









Figure 4. Hydrogen peroxide scavenging capabilities of MPAs from the (A) Benzoic 
acid group and (B) Cinnamic acid group in comparison to their unmodified controls. 
 
3.2 PA and MPA Antimicrobial Properties 
3.2.1 DMSO Bacterial Toxicity 
Before testing PA and MPA antimicrobial properties, a test was run with each bacteria 
strain to find the maximum volume of DMSO that could be used to dissolve PAs and 
MPAs without affecting bacteria growth. Figure 5 shows the DMSO test results over 24 






Staph. aureus, native and drug-resistant). From the data, we could see that the different 
bacteria strains have variable maximum DMSO volume tolerance. For E. coli in Figure 
5A, the O.D. values (i.e. bacteria density) with exposure to 8 μl DMSO are comparable to 
those of the control group (0 μl DMSO) over 24 hours; however, the O.D. values were 
greatly decreased compared to the control group with exposure to 16 μl DMSO. Therefore, 
each concentration of PAs was dissolved in 5 μl DMSO for E. coli tests to ensure that 
DMSO did not affect PA characterization. In Figure 5B, it can be seen that the O.D. 
values for Staph. epi. native strain did not show great decrease compared with the control 
group over 24 hours with exposure to up to 16 μl DMSO. In Figure 5C, 16 μl DMSO did 
not affect Staph. epi. drug-resistant strain growth at 4 hours, and a slight increase in 
growth can be observed at 24 hours with 16 μl DMSO. These results were attributed to 
the fact that different organisms will respond individually to the same amount and 
concentration of one particular organic solvent.[38] Therefore, PAs were dissolved in 10 
μl DMSO for both Staph. epi. native and drug-resistant strains. From Figure 5D, 16 μl 
DMSO did not greatly affect the O.D. value for Staph. aureus over 4 hours compared with  
the control group, but bacteria growth was decreased at 24 hours for all concentrations 
of DMSO. From Figure 5E, 16 μl DMSO slightly decreased the O.D. values for drug-
resistant Staph. aureus over 24 hours, to the lesser extent than the 32 μl DMSO. In 
consideration of PA’s solubility and these results, PAs were dissolved in 10 μl DMSO for 













Figure 5. DMSO maximum volume test over 24 hours with (A) E. coli, (B) Staph. epi. 
native strain, (C) Staph. epi. drug-resistant strain, (D) Staph. aureus native strain, and 


























3.2.2 PA IC50  
Upon determination of appropriate amounts of DMSO for each test, the antimicrobial 
properties of PAs and MPAs were characterized in terms of IC50 value (concentration 
required to kill 50% of cells) and log reduction value (number of cells killed in comparison 
with media control).  
The IC50 results are shown in Figures 6-7. The lack of data for CA and CAA is 
because of limited solubility and color change that affected absorbance measurements. 
From Figure 6A and 6B, it can be seen that the IC50 value of each PA have increased 
from 4 to 24 hours, which means PA antimicrobial capabilities generally decrease with 
time for E. coli and Staph. epi., In particular, protocatechuic acid (PA) and syringic acid 
(SYA) in the BA group and ferulic acid (FA) and sinapic acid (SA) in the CA group show 
large decreases in antimicrobial properties with time. These reductions in efficacy over 
time are likely due to a combination of bacterial uptake of PA to reduce effective 
concentration during live bacterial growth. As shown in Figure 6C, the IC50 value of each 
PA have decreased between 4 to 24 hours, which means PA’s antimicrobial capabilities 
increase with time for Staph. aureus. From Figure 7A, we can see that the IC50 value of 
each PA decreased from 4 to 24 hours for drug-resistant Staph. epi., indicating that PAs 
have increased antimicrobial capabilities over time with this bacterial strain. The opposite 
trend can be viewed in Figure 7B, where PA IC50s increase from 4 to 24 hours, indicating 








          
          
          
Figure 6. IC50 results of (left) Benzoic acid group and (right) Cinnamic acid group 
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Figure 7. IC50 results of (left) Benzoic acid group and (right) Cinnamic acid group 
against drug-resistant (A) Staph. epi. and (B) Staph. aureus. 
 
It could be observed from the experiment that CA solubility improved over time in the 
presence of bacteria strains, and CA solubility didn’t change without the presence of 
bacteria. This finding could provide the basis of future studies, for example, an experiment 
could be designed to test if the solubility change is due to digestion by bacterial proteases, 
and a mutant strain that doesn’t release protease could be applied in the test. Also, it 
could be tested if CA is taken up over time, spectroscopy techniques could be applied to 



















































































Three important results that can be gleaned from this data include: (1) All PAs show 
some efficacy against all tested bacteria strains, indicating their potential for use in wound 
infection prevention. (2) PA IC50 values are within the range of possible incorporation 
into SMP scaffolds, and (3) PAs are equally effective against native and drug-resistant 
strains of Staph. epi. and Staph. aureus. Beyond this project, this study provides essential 
information that could be utilized in PA use in other biomaterial systems to provide 
localized antimicrobial properties.  
Except for the polymers with improved antimicrobial properties demonstrated above, 
phenolic acids could also incorporate with natural rubber (NR) forming SMPs with tunable 
triggering temperature. They can form a epoxidized natural rubber crosslinked network 
with excellent shape memory effect.[39] 
 
3.2.3 Log Reduction  
Bacterial log reductions in the presence of the selected PAs are shown in Figures 
8-9. 
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Figure 8. Native (A) E. coli, (B) Staph. epi., and (C) Staph. aureus log reduction in 
presence of (left) Benzoic acid group and (right) Cinnamic acid group at 5 mg PA/ml. 
 
 



































































































































          
Figure 9. Drug-resistant (A) Staph. epi. and (B) Staph. aureus log reduction in presence 
of (left) Benzoic acid group and (right) Cinnamic acid group at 5 mg PA/ml. 
 
The data collected in Figure 8 is based on the O.D. value of 5 mg/ml PA solutions 
collected in the 96 well plate, the lack of some data is due to solubility issues that affected 
absorbance measurements. In general, a larger log reduction corresponds with improved 
antimicrobial capacity. From Figure 8A, except for the PAs without log reduction data, 
only BA shows consistently increased antimicrobial capability over the full 24 hours for E. 
coli. However, all PAs with available data show a log reduction of ~0.8 at 4 hours, which 
is comparable to that of the drug control, indicating initial antimicrobial properties at 
clinically effective levels. In contrast, Figure 8B and 8C show that the log reduction value 
and antimicrobial capability of all tested PAs increased with time for Staph. epi. and Staph. 
aureus. These differences are likely due to differences in bacterial growth rates. 
Additionally, the uptake of PAs into gram positive bacteria (Staph. epi. and Staph. aureus) 
may be more effective than that into gram negative E. coli due to differences in the cell 
walls. Based on the potential mechanisms of PA’s antimicrobial properties, the 




















































properties of PA. Because PAs could alter bacteria’s surface tension components, they 
can also change the hydrophobicity and electron receptors (receptor components 
increase on gram-positive, decrease on gram-negative) on the bacterial cell surface. 
Therefore, gram negative E. coli shows different results compared with other bacteria 
strains. In Figure 9A and 9B, it can be seen that the antimicrobial capability of each PA 
is increased over time for drug-resistant Staph. epi. and Staph. aureus to comparable 
levels to those seen in the native strains. These results confirm the IC50 results and show 
that only 5 mg PA/ml is required for effective antimicrobial properties at levels that are 
comparable to drugs. Previously synthesized SMP foams with cinnamic acid contained 
between ~5 and 20 mg CA/ml (cm3) of foam. 
Compared with those previously presented in the literature, the antimicrobial results 
of CA in this paper show the same outstanding antimicrobial properties on E. coli and 
Staph. epi..[27] However, there are also some differences, some results in previous 
literature show that protocatechuic acid demonstrates high antimicrobial capacity on 
gram-positive bacteria strains,[40] which could not be seen in the results of this paper. 
According to PA’s antimicrobial mechanisms, one possible explanation for this 
difference could be the different proportions of lipids and phospholipids contained in the 
cell walls of the bacteria strain (Bacillus cereus) used in the previous literature.[41] 
 
3.2.4 Colony Forming Units 
The antimicrobial properties of PAs with limited solubility (cinnamic acid (CA), sinapic 
acid (SA), p-coumaric acid (PCA), and syringic acid (SYA)) and the synthesized MPAs 




the multi-well plate assay. The sediment that was present with these PAs and MPAs 
blocked the travel of light through the sample, affecting measurements of bacteria density 
via absorbance. Therefore, a Petri dish assay is utilized to quantify the antimicrobial 
properties of PAs and MPAs with limited solubility in terms of colony forming units (CFUs) 
over time, as shown in Figures 10-12.  
 
           








































































         
Figure 10. CFU counts of (A) E. coli, (B) native Staph. epi., (C) native Staph. aureus, 
(D) drug-resistant Staph. epi., and (E) Drug-resistant Staph. aureus after exposure to 
PAs with limited solubility. 
 
The CFU results were quantified based off of ¼ the plate area using ImageJ software. 
Compared with LB and DMSO, it could be seen that all PAs with limited solubility are 
effective for 5 selected bacteria strains to levels that are comparable to the penicillin 
control, with the exception of SA and E. coli, Figure 10. In general, CA shows the best 
antimicrobial property among all the PAs with limited solubility, as there were no visible 
CFUs after 24 hours of exposure to CA. Again, comparable efficacy was observed with 
native and drug-resistant strains, indicating PA efficacy against drug-resistant bacteria, 
even when not fully solubilized. 
The CFU results of MPAs in comparison with their PA controls are shown on Figures 
11 (native strains) and 12 (drug-resistant strains). All MPAs showed comparable results 
to their corresponding PAs for all bacteria strains. In general, PAs and MPAs were highly 
effective and reducing bacteria CFUs in the gram-positive strains (native and drug-

















































comparison with LB and DMSO. It should be noted that the unmodified PA CFU results 
are different from those observed in Figure 10. Thus, these studies should be repeated 
to verify PA efficacy against E. coli. However, the comparable CFU trends between PAs 
and corresponding MPAs over 24 hours of exposure indicates that PA modification at the 
carboxylic acid group, which is required for incorporation into SMPs, does not alter 
antimicrobial characteristics. 
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Figure 11. Native (A) E. coli, (B) Staph. epi., and (C) Staph. aureus CFU counts in 
































































           
          
Figure 12. Drug-resistant (A) Staph. epi. and (B) Staph. aureus CFU counts in 
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 These studies provide the first systematic characterization of PAs in terms of 
structure and antioxidant and antimicrobial properties with an emphasis on antimicrobial 
efficacy against common wound pathogens. The data collected thus far on modified PAs 
indicates that the carboxylic acid groups on PAs can be reacted with SMP components 
without loss in antioxidant or antimicrobial functionality. In general, hydrogen peroxide 
scavenging capabilities of phenolic acids increase with increasing radical scavenging 
pendant groups, eliminating cinnamic, benzoic, and 4-hydroxy benzoic acids as potential 
antioxidants. No consistent trends were observed between antimicrobial capacity and PA 
structure. While all PAs showed efficacy against all tested strains, there were variations 
in antimicrobial properties. PAs that had IC50 values greater than 10 mg/ml, maximum 
log reduction values below 0.7, and/or CFU counts above 100 include sinapic acid, 
syringic acid, and protocatachuic acid. Thus, these PAs will not be pursued in future 
studies required for antimicrobial SMPs. While solubility did not show a direct effect on 
functionality, limited solubility can hinder effective reactions between PAs and SMP 
components. Those PAs which have limited solubility include cinnamic acid, sinapic acid, 
p-coumaric acid, and syringic acid. Thus, these PAs will be given lower priority in future 
studies. Based on these trends, ferulic, caffeic, and vanillic acids will be pursued in future 
studies of synthesis of antioxidant and antimicrobial SMPs for use in hemorrhage control, 
Figure 13. This thesis provides a foundation for rational design of PA-containing 
biomaterial scaffolds with desired functionality that could be used in a range of 
applications where antioxidant and/or antimicrobial properties are required for improved 




Figure 13. PA library down-selection for future incorporation into SMPs. Grey bars: No 
antioxidant efficacy. Red bars: Reduced antimicrobial efficacy. Blue bars: Limited 
solubility.  
 
This research will guide future research on the rational synthesis of function foams 
with antioxidants, more studies could be on the synthesizing processes of improving PA 
content into the SMPs, which will enable SMPs to have better desired charasteristics. 
With the secreeing of 10 selected PAs, the PA library has been narrowed, which will help 
the future incorporating selection. Also, this research provides new fundamental 
information on PA structure/prooerty relationships, especially the relationship between 
PA structures and antioxidant properties. The future direction of this research is to test 
multiple bacteria strains together and test with biofilms. Because the battlefiled is a 
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